Sources | Names Used |
---|---|
CTRPv2 | JQ-1:MK-0752 (1:1 mol/mol) |
PharmacoGx | JQ-1:MK-0752 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TOP1MT | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | EXOC6B | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
mRNA | FNDC8 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | EIF3I | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | CA13 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | TMEM216 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | TAS2R43 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | TAF13 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | RANBP9 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | CASP9 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |